Eupraxia Pharmaceuticals Correlations

EPRX Stock

3.38 0.16 4.52%

The current 90-days correlation between Eupraxia Pharmaceuticals and Nathans Famous is 0.24 (i.e., Modest diversification). The correlation of Eupraxia Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Eupraxia Pharmaceuticals Correlation With Market

Average diversification

The correlation between Eupraxia Pharmaceuticals Commo and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and DJI in the same portfolio, assuming nothing else is changed.

The ability to find closely correlated positions to Eupraxia Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Eupraxia Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Eupraxia Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Eupraxia Pharmaceuticals Common to buy it.

Moving together with Eupraxia Pink Sheet

0.93	VIRX	Viracta Therapeutics	Pair Corr
0.63	MDCX	Medicus Pharma Downward Rally	Pair Corr
0.61	NAGE	Niagen Bioscience, Symbol Change	Pair Corr
0.77	PVLA	Palvella Therapeutics, Symbol Change	Pair Corr

Moving against Eupraxia Pink Sheet

0.89	HURA	TuHURA Biosciences Symbol Change	Pair Corr
0.78	MTVA	MetaVia Symbol Change	Pair Corr
0.77	GRCE	Grace Therapeutics, Symbol Change	Pair Corr
0.73	WHWK	WHWK Symbol Change	Pair Corr
0.62	KLTOW	Klotho Neurosciences, Symbol Change	Pair Corr
0.61	IRD	Opus Genetics, Symbol Change	Pair Corr
0.61	MDCXW	Medicus Pharma	Pair Corr
0.59	FBIOP	Fortress Biotech Pref	Pair Corr
0.58	OKUR	OnKure Therapeutics, Symbol Change	Pair Corr
0.58	PLRZ	Polyrizon Ordinary	Pair Corr
0.55	NWBO	Northwest Biotherapeutics	Pair Corr
0.45	UPB	Upstream Bio,	Pair Corr
0.44	JUNS	Jupiter Neurosciences,	Pair Corr
0.89	ASBP	Aspire BioPharma, Symbol Change	Pair Corr
0.81	SEPN	Septerna, Common Stock	Pair Corr
0.78	CLYM	Climb Bio Symbol Change	Pair Corr
0.73	GELS	Gelteq Limited Ordinary	Pair Corr
0.6	ATR	AptarGroup	Pair Corr
0.58	NAYA	NAYA Biosciences, Symbol Change	Pair Corr
0.53	SYRS	Syros Pharmaceuticals	Pair Corr
0.51	TVGNW	Tevogen Bio Holdings	Pair Corr
0.51	GRDN	Guardian Pharmacy	Pair Corr

Related Correlations Analysis

	NATH	KDP	PTLO	DPZ	KO	SNDVF	SG
NATH		0.77	0.57	0.7	0.85	0.61	-0.92	NATH
KDP	0.77		0.24	0.56	0.86	0.59	-0.76	KDP
PTLO	0.57	0.24		0.69	0.48	0.56	-0.44	PTLO
DPZ	0.7	0.56	0.69		0.72	0.49	-0.63	DPZ
KO	0.85	0.86	0.48	0.72		0.62	-0.85	KO
SNDVF	0.61	0.59	0.56	0.49	0.62		-0.57	SNDVF
SG	-0.92	-0.76	-0.44	-0.63	-0.85	-0.57		SG
	NATH	KDP	PTLO	DPZ	KO	SNDVF	SG

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

KO	+ 0.86	KDP
KO	+ 0.85	NATH
KDP	+ 0.77	NATH
KO	+ 0.72	DPZ
DPZ	+ 0.7	NATH
DPZ	+ 0.69	PTLO

High negative correlations

SG	- 0.92	NATH
SG	- 0.85	KO
SG	- 0.76	KDP
SG	- 0.63	DPZ
SG	- 0.57	SNDVF
SG	- 0.44	PTLO

Risk-Adjusted Indicators

There is a big difference between Eupraxia Pink Sheet performing well and Eupraxia Pharmaceuticals Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Eupraxia Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
NATH	1.50	0.37	0.26	0.34	1.17	(1.87)	2.68	(2.16)	18.28
KDP	1.04	0.09	0.11	(7.68)	1.30	(1.11)	2.20	(2.36)	6.16
PTLO	3.12	0.60	0.18	0.32	2.88	(3.89)	8.12	(5.06)	22.46
DPZ	1.54	0.17	0.11	8.29	1.86	(1.71)	3.48	(3.02)	12.17
KO	0.92	0.18	0.24	(0.58)	0.85	(1.03)	1.87	(1.53)	7.65
SNDVF	0.51	0.26	0.00	2.93	0.00	0.00	2.53	0.00	7.98
SG	2.99	(0.24)	0.00	(0.36)	0.00	0.00	5.41	(8.59)	16.63

Eupraxia Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Eupraxia Pharmaceuticals pink sheet to make a market-neutral strategy. Peer analysis of Eupraxia Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Eupraxia Pharmaceuticals by comparing valuation metrics with similar companies.

Nathans Famous Keurig Dr Pepper Portillos Dominos Pizza Common The Coca Cola Scandinavian Tobacco Group Sweetgreen American Airlines Group Alcoa Corp Apple Inc Best Buy Co Citigroup SentinelOne CVS Health Corp Chevron Corp

Risk & Return

Correlation

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC